Test–retest repeatability of organ uptake on PSMA‐targeted 18F‐DCFPyL PET/CT in patients with prostate cancer

Authors: Werner, Rudolf A., Lütje, Susanne, Habacha, Bilêl, Bundschuh, Lena, Higuchi, Takahiro, Buck, Andreas K., Kosmala, Aleksander, Lapa, Constantin, Essler, Markus, Lodge, Martin A., Pienta, Kenneth J., Eisenberger, Mario A., Markowski, Mark C., Gorin, Michael A., Pomper, Martin G., Rowe, Steven P., Bundschuh, Ralph A.

Source: Prostate. 83(12):1186-1192

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187897072.0x000001&indx=1&recIds=ETOCvdc_100187897072.0x000001

Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial

Authors: Tran, Phuoc T., Lowe, Kathryn, Tsai, Hua-Ling, Song, Daniel Y., Hung, Arthur Y., Hearn, Jason W.D., Miller, Steven, Proudfoot, James A., Deek, Matthew P., Phillips, Ryan, Lotan, Tamara, Paller, Channing J., Marshall, Catherine H., Markowski, Mark, Dipasquale, Shirl, Denmeade, Samuel, Carducci, Michael, Eisenberger, Mario, DeWeese, Theodore L., Orton, Matthew, Deville, Curtiland, Davicioni, Elai, Liauw, Stanley L., Heath, Elisabeth I., Greco, Stephen, Desai, Neil B., Spratt, Daniel E., Feng, Felix, Wang, Hao, Beer, Tomasz M., Antonarakis, Emmanuel S.

Source: Journal of clinical oncology. 41(6):1307-1317

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100183180205.0x000001&indx=1&recIds=ETOCvdc_100183180205.0x000001

Lack of repeatability of radiomic features derived from PET scans: Results from a 18F‐DCFPyL test–retest cohort

Authors: Werner, Rudolf A., Habacha, Bilêl, Lütje, Susanne, Bundschuh, Lena, Kosmala, Alekandser, Essler, Markus, Derlin, Thorsten, Higuchi, Takahiro, Lapa, Constantin, Buck, Andreas K., Pienta, Kenneth J., Lodge, Martin A., Eisenberger, Mario A., Markowski, Mark C., Pomper, Martin G., Gorin, Michael A., Frey, Eric C., Rowe, Steven P., Bundschuh, Ralph A.

Source: Prostate. 83(6):547-554

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100182200085.0x000001&indx=1&recIds=ETOCvdc_100182200085.0x000001

Association between baseline body mass index and survival in men with metastatic hormone‐sensitive prostate cancer: ECOG‐ACRIN CHAARTED E3805

Authors: Morgans, Alicia K., Chen, Yu‐Hui, Jarrard, David F., Carducci, Michael, Liu, Glenn, Eisenberger, Mario, Plimack, Elizabeth R., Bryce, Alan, Garcia, Jorge A., Dreicer, Robert, Vogelzang, Nicholas J., Picus, Joel, Shevrin, Daniel, Hussain, Maha, DiPaola, Robert S., Cella, David, Sweeney, Christopher J.

Source: Prostate. 82(12):1176-1185

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100157127886.0x000001&indx=1&recIds=ETOCvdc_100157127886.0x000001

Impact of PSA nadir on long-term survival in metastatic hormone-sensitive prostate cancer: Final 10-year analysis of the ECOG-ACRIN E3805 CHAARTED trial.

Authors: Tripathi, Abhishek, Chen, Yu-Hui, Jarrard, David Frazier, Garcia, Jorge A., Dreicer, Robert, Liu, Glenn, Hussain, Maha H. A., Shevrin, Daniel, Cooney, Matthew M., Eisenberger, Mario A., Kohli, Manish, Plimack, Elizabeth R., Vogelzang, Nicholas J., Picus, Joel, Carducci, Michael A, DiPaola, Robert S., Sweeney, Christopher

Source: Journal of Clinical Oncology; 2/20/2025 Supplement 5, Vol. 43, p167-167, 288p

The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited

Authors: Deek, Matthew P., Van der Eecken, Kim, Phillips, Ryan, Parikh, Neil R., Isaacsson Velho, Pedro, Lotan, Tamara L., Kishan, Amar U., Maurer, Tobias, Boutros, Paul C., Hovens, Christopher, Abramowtiz, Matthew, Pollack, Alan, Desai, Neil, Stish, Bradley, Feng, Felix Y., Eisenberger, Mario, Carducci, Michael, Pienta, Kenneth J., Markowski, Mark, Paller, Channing J., Antonarakis, Emmanuel S., Berlin, Alejandro, Ost, Piet, Tran, Phuoc T.

Source: In European Urology November 2021 80(5):632-640

Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine

Authors: Jasu, Juho, Tolonen, Teemu, Antonarakis, Emmanuel S., Beltran, Himisha, Halabi, Susan, Eisenberger, Mario A., Carducci, Michael A., Loriot, Yohann, Van der Eecken, Kim, Lolkema, Martijn, Ryan, Charles J., Taavitsainen, Sinja, Gillessen, Silke, Högnäs, Gunilla, Talvitie, Timo, Taylor, Robert J., Koskenalho, Antti, Ost, Piet, Murtola, Teemu J., Rinta-Kiikka, Irina, Tammela, Teuvo, Auvinen, Anssi, Kujala, Paula, Smith, Thomas J., Kellokumpu-Lehtinen, Pirkko-Liisa, Isaacs, William B., Nykter, Matti, Kesseli, Juha, Bova, G. Steven ^*

Source: In European Urology Open Science August 2021 30:47-62

Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNA

Authors: Sumanasuriya, Semini, Seed, George, Parr, Harry, Christova, Rossitza, Pope, Lorna, Bertan, Claudia, Bianchini, Diletta, Rescigno, Pasquale, Figueiredo, Ines, Goodall, Jane, Fowler, Gemma, Flohr, Penelope, Mehra, Niven, Neeb, Antje, Rekowski, Jan, Eisenberger, Mario, Sartor, Oliver, Oudard, Stéphane, Geffriaud-Ricouard, Christine, Ozatilgan, Ayse, Chadjaa, Mustapha, Macé, Sandrine, Lord, Chris, Baxter, Joe, Pettitt, Stephen, Lambros, Maryou, Sharp, Adam, Mateo, Joaquin, Carreira, Suzanne, Yuan, Wei, de Bono, Johann S. ^⁎

Source: In European Urology August 2021 80(2):243-253

A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts

Authors: Markowski, Mark C., Wang, Hao, Sullivan, Rana, Rifkind, Irina, Sinibaldi, Victoria, Schweizer, Michael T., Teply, Benjamin A., Ngomba, Nduku, Fu, Wei, Carducci, Michael A., Paller, Channing J., Marshall, Catherine H., Eisenberger, Mario A., Luo, Jun, Antonarakis, Emmanuel S., Denmeade, Samuel R.

Source: In European Urology May 2021 79(5):692-699

Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy

Authors: Sena, Laura A., Wang, Hao, Lim ScM, Su J., Rifkind, Irina, Ngomba, Nduku, Isaacs, John T., Luo, Jun, Pratz, Caroline, Sinibaldi, Victoria, Carducci, Michael A., Paller, Channing J., Eisenberger, Mario A., Markowski, Mark C., Antonarakis, Emmanuel S., Denmeade, Samuel R.

Source: In European Journal of Cancer February 2021 144:302-309

Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate Cancer

Authors: Deek, Matthew P., Taparra, Kekoa, Dao, Dyda, Chan, Luanna, Phillips, Ryan, Gao, Robert W., Kwon, Eugene D., Deville, Curtiland, Song, Daniel Y., Greco, Stephen, Carducci, Michael A., Eisenberger, Mario, DeWeese, Theodore L., Denmeade, Samuel, Pienta, Kenneth, Paller, Channing J., Antonarakis, Emmanuel S., Olivier, Kenneth R., Park, Sean S., Stish, Bradley J., Tran, Phuoc T.

Source: International journal of radiation oncology, biology, physics. 109(2):387-395

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100138551722.0x000001&indx=1&recIds=ETOCvdc_100138551722.0x000001

Detection of Early Progression with ^1^8F-DCFPyL PET/CT in Men with Metastatic Castration-Resistant Prostate Cancer Receiving Bipolar Androgen Therapy

Authors: Markowski, Mark C., Velho, Pedro Isaacsson, Eisenberger, Mario A., Pomper, Martin G., Pienta, Kenneth J., Gorin, Michael A., Antonarakis, Emmanuel S., Denmeade, Samuel R., Rowe, Steven P.

Source: Journal of nuclear medicine. 62(9):1270-1273

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN627421850&indx=1&recIds=ETOCRN627421850

Post Hoc Health‐Related Quality of Life Analysis According to Response Among Patients with Prostate Cancer in the PROSELICA and FIRSTANA Studies

Authors: Thiery‐Vuillemin, Antoine, Fizazi, Karim, Sartor, Oliver, Oudard, Stéphane, Bury, Denise, Ozatilgan, Ayse, Poole, Elizabeth M., Eisenberger, Mario, Bono, Johann

Source: Oncologist. 26(7):e1179-e1188

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100123837008.0x000001&indx=1&recIds=ETOCvdc_100123837008.0x000001

Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial

Authors: Shenderov, Eugene, Boudadi, Karim, Fu, Wei, Wang, Hao, Sullivan, Rana, Jordan, Alice, Dowling, Donna, Harb, Rana, Schonhoft, Joseph, Jendrisak, Adam, Carducci, Michael A., Eisenberger, Mario A., Eshleman, James R., Luo, Jun, Drake, Charles G., Pardoll, Drew M., Antonarakis, Emmanuel S.

Source: Prostate. 81(6):326-338

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100116967691.0x000001&indx=1&recIds=ETOCvdc_100116967691.0x000001

Olaparib Without Androgen Deprivation for High-Risk Biochemically Recurrent Prostate Cancer Following Prostatectomy: A Nonrandomized Controlled Trial.

Authors: Marshall, Catherine H., Teply, Benjamin A., Lu, Jiayun, Oliveira, Lia, Wang, Hao, Mao, Shifeng S., Kelly, W. Kevin, Paller, Channing J., Markowski, Mark C., Denmeade, Samuel R., King, Serina, Sullivan, Rana, Davicioni, Elai, Proudfoot, James A., Eisenberger, Mario A., Carducci, Michael A., Lotan, Tamara L., Antonarakis, Emmanuel S.

Source: JAMA Oncology; Oct2024, Vol. 10 Issue 10, p1400-1408, 9p

Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate

Authors: Heaphy, Christopher M., Haffner, Michael C., Graham, Mindy K., Lim, David, Davis, Christine, Corey, Eva, Epstein, Jonathan I., Eisenberger, Mario A., Wang, Hao, De Marzo, Angelo M., Meeker, Alan K., Lotan, Tamara L.

Source: In Human Pathology July 2020 101:70-79

Impact of progression at baseline and on-treatment progression events in three large prostate cancer trials

Authors: Robbrecht, Debbie G., Delanoy, Nicolas, Tannock, Ian F., Tombal, Bertrand, Eisenberger, Mario, Fizazi, Karim, Sartor, Oliver, Mercier, Florence, Oudard, Stephane, de Wit, Ronald

Source: In European Journal of Cancer January 2020 125:142-152

Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer

Authors: Isaacsson Velho, Pedro, Fu, Wei, Wang, Hao, Mirkheshti, Nooshin, Qazi, Fahad, Lima, Fabiola A.S., Shaukat, Farah, Carducci, Michael A., Denmeade, Samuel R., Paller, Channing J., Markowski, Mark C., Marshall, Catherine H., Eisenberger, Mario A., Antonarakis, Emmanuel S.

Source: In European Urology January 2020 77(1):14-21

PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

Authors: Markowski, Mark C., Chen, Yongmei, Feng, Zhaoyong, Cullen, Jennifer, Trock, Bruce J., Suzman, Daniel, Antonarakis, Emmanuel S., Paller, Channing J., Rosner, Inger, Han, Misop, Walsh, Patrick C., Partin, Alan W., Eisenberger, Mario

Source: In Clinical Genitourinary Cancer December 2019 17(6):470-475

Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations

Authors: Marshall, Catherine H., Sokolova, Alexandra O., McNatty, Andrea L., Cheng, Heather H., Eisenberger, Mario A., Bryce, Alan H., Schweizer, Michael T., Antonarakis, Emmanuel S.

Source: In European Urology October 2019 76(4):452-458